ProSense cryoablation system gains marketing authorization as the first minimally invasive treatment for low-risk tumors in women over 70.
Market reacts sharply to the newly combined company's strategic pivot from pharmaceuticals to HR technology and a new capital structure.
Agreement with White Lion Capital gives the network solutions provider the right to sell shares, securing access to growth capital.
H.C. Wainwright more than doubles its price target to $7.00, citing growing cost-competitiveness for the green hydrogen industry.
A significant analyst price target hike for Quantum Computing Inc. (QUBT) fuels a massive rally in the leveraged ETF.
Regulators expedite review for ALTO-101, a novel treatment for cognitive impairment in schizophrenia, a condition with no currently approved therapies.
Shares surge over 76% as the company secures Nevada Tech Hub funding and a key U.S. patent for its charging technology.
The newly formed company, which began trading on Nasdaq this week, faces intense volatility following the finalized deal and ahead of a planned reverse stock split.